Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1129, 2006-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Higher thrombocytopenia risk with abciximab than with tirofiban
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Access to resources
Recommend
Linezolid-related thrombocytopenia rates higher than expected
Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. :
Benefit-Risk Assessment of Treatments for Heparin-Induced Thrombocytopenia
Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. :
Amiodarone: no higher risk with generic version
Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. :
Celecoxib CV risk increased at higher dosages
Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. :